Why IREN stock is rising today: AI data-center optimism lifts the bitcoin miner-turned-cloud play

Why IREN stock is rising today: AI data-center optimism lifts the bitcoin miner-turned-cloud play

NEW YORK, January 8, 2026, 10:39 EST — Regular session

  • IREN shares rose about 4.3% in morning trading, snapping a two-day slide.
  • AI data-center names drew fresh bids after Applied Digital beat revenue estimates.
  • Traders are watching mid-February earnings timing and Friday’s U.S. jobs report.

Shares of IREN Ltd (IREN.O) climbed about 4.3% to $45.49 on Thursday, as investors returned to data-center names tied to artificial intelligence computing demand. The stock touched a session high of $45.49 after dipping as low as $42.69.

IREN runs renewable-powered data centers used for bitcoin mining and for renting out AI computing capacity. Its AI cloud unit uses graphics processing units (GPUs) — the chips used to train and run AI models — leaving the stock straddling crypto swings and the tight supply of high-end compute. Bitcoin was down about 1% at around $90,300. 1

The tone improved after a strong print from Applied Digital, another data-center operator that has pushed into AI hosting. Applied reported quarterly revenue of $126.6 million, beating analysts’ $88 million estimate, and its shares rose about 11.5% in early trade; crypto miner Cipher Mining was little changed.

Valuation is still the sticking point for some investors after IREN’s run. Subhasish Mukherjee of Zacks Investment Research wrote on Wednesday that IREN shares were “currently overvalued” on a trailing price-to-sales basis — a measure that compares a company’s market value with its revenue — and said the stock was trading below its 50-day moving average, a common short-term trend gauge. 2

The longer-term bull case rests on how fast IREN can turn power and concrete into contracted AI revenue. In its last quarterly update, the company said it was targeting $3.4 billion in AI cloud annualized run-rate revenue (ARR) by end-2026 — essentially the revenue pace annualized from current contracts and usage — supported by an expansion to 140,000 GPUs, and it flagged an April 2026 energization target for its Sweetwater 1 substation. 3

IREN also has a $9.7 billion, five-year AI cloud deal with Microsoft that Reuters reported in November, with phased deployments through 2026 and Nvidia chips supplied via Dell. Microsoft said at the time it could terminate the contract if IREN misses delivery schedules. 4

The shares have been volatile this week. They fell about 5% on Wednesday after a roughly 4.8% drop a day earlier, according to price data. 5

But the ramp is capital-heavy and time-sensitive. Any slip in power hookups, construction timelines or chip deliveries can push out revenue, while a weaker bitcoin price can squeeze cash generation from the mining side just as funding needs rise.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Intel stock slides after 18A ‘Panther Lake’ rally — Jan. 22 earnings is the next test
Previous Story

Intel stock slides after 18A ‘Panther Lake’ rally — Jan. 22 earnings is the next test

Nvidia stock slips as China buyers face “pay upfront” rule for H200 AI chips
Next Story

Nvidia stock slips as China buyers face “pay upfront” rule for H200 AI chips

Go toTop